|
Philip Wagenheim
Managing Partner
Broadband Capital
|
Mr. Wagenheim has more than 28 years of experience in the financial industry and is the Managing Partner of Broadband Capital Partners, LLC, a middle-market private equity sponsor focused on growth companies and industry consolidations. Prior to Broadband Capital Partners, he was the vice-chairman of Broadband Capital Management LLC, an investment and merchant bank he co-founded in 2000. Mr. Wagenheim has extensive experience with public and private growth equity investments, including Immunome Inc (NASDAQ: IMNM), Zynerba Pharmaceuticals (Nasdaq: ZYNE), ExamWorks, Vroom.com (Nasdaq: VRM), Montrose Environmental Group (NYSE: MEG), Hydrofarm Holdings Group (NASDAQ: HYFM). Mr. Wagenheim has served as a member of the board of directors of Immunome Inc. since December 2017 and served as its Interim Chief Executive Officer from January 2017 to March 2017. In connection with Zynerba’s recapitalization, Mr. Wagenheim was named President and a Director of the company, serving as a director until the company’s initial public offering in August 2015 led by Jefferies and Piper Jaffray. Mr. Wagenheim received his degree in Business Administration from the University of Miami.